Trial Profile
Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone Percutaneous Coronary Intervention - a Randomised, Crossover Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Mar 2016
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 10 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 18 Jun 2015 New trial record